Provided by Tiger Trade Technology Pte. Ltd.

Artelo Biosciences, Inc.

0.6920
-0.0204-2.86%
Post-market: 0.6815-0.0105-1.52%19:09 EDT
Volume:108.90K
Turnover:76.98K
Market Cap:3.18M
PE:-0.06
High:0.7300
Open:0.7200
Low:0.6803
Close:0.7124
52wk High:28.98
52wk Low:0.6803
Shares:4.60M
Float Shares:4.35M
Volume Ratio:0.07
T/O Rate:2.50%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-11.3794
EPS(LYR):-37.5481
ROE:-705.71%
ROA:-127.92%
PB:0.64
PE(LYR):-0.02

Loading ...

Artelo Biosciences Launches Flexible At-The-Market Offering

TIPRANKS
·
May 28

Top Premarket Decliners

MT Newswires Live
·
May 27

Artelo Biosciences announces annual shareholder meeting

Reuters
·
May 27

Artelo Biosciences Inc - to Offer up to $6.53 Mln in Common Stock via H.c. Wainwright - SEC Filing

THOMSON REUTERS
·
May 27

Top Premarket Gainers

MT Newswires Live
·
May 26

Wall Street Expands Crypto Asset Integration as SEC Approves Nasdaq's Bitcoin Options Product

Stock News
·
May 23

Global Financial Headlines: Pershing Square Takes Position in Microsoft, Mehlan Steps Down from Fed, SpaceX Picks Nasdaq for IPO

Deep News
·
May 16

Artelo Biosciences Ends ATM Offering, Shifts Financing Strategy

TIPRANKS
·
May 16

Artelo Biosciences Inc - to Terminate at-the-Market Offering Agreement Effective May 18, 2026 - SEC Filing

THOMSON REUTERS
·
May 16

Dollar's Resurgence Weighs on Gold as Tech Stocks Face Potential Pressure

Deep News
·
May 15

Artelo Biosciences Q1 EPS $(4.00) Misses $(1.57) Estimate

Benzinga Earnings
·
May 15

Artelo Biosciences Q1 FY26 net loss widens 24.7% to USD 2.96 million

Reuters
·
May 15

Artelo Biosciences Provides Business Update Outlining Upcoming Milestones and Reports 2026 First Quarter Financial Results

THOMSON REUTERS
·
May 15

BRIEF-Artelo Biosciences May Offer Securities Up To $75 Million - SEC Filing

Reuters
·
May 05

Artelo Biosciences files $75M mixed securities shelf

TIPRANKS
·
May 05

Artelo Biosciences Inc - May Offer Securities up to $75 Mln - SEC Filing

THOMSON REUTERS
·
May 05

Artelo Biosciences partners with ScienceMachine to accelerate FABP5 inhibitor development

Reuters
·
Apr 28

Artelo Biosciences Inc - Announces Strategic Partnership With Sciencemachine for Fabp5 Inhibitor Development

THOMSON REUTERS
·
Apr 28

Artelo advances ART26.12 into multiple ascending dose trial after Phase 1 safety data

Reuters
·
Apr 20

Alamar Biosciences Surges on Nasdaq Debut, Reaches $1.53 Billion Valuation

Deep News
·
Apr 18